The University of Chicago Header Logo

Connection

Michael P Blair to Antibodies, Monoclonal

This is a "connection" page, showing publications Michael P Blair has written about Antibodies, Monoclonal.
Connection Strength

0.579
  1. Bevacizumab for ROP. Ophthalmology. 2012 Feb; 119(2):431-2; author reply 432.
    View in: PubMed
    Score: 0.266
  2. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
    View in: PubMed
    Score: 0.240
  3. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
    View in: PubMed
    Score: 0.057
  4. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.